Simultaneous determination of tenoxicam and 2-aminopyridine using derivative spectrophotometry and high-performance liquid chromatography

被引:25
作者
ElWalily, AFM [1 ]
Blaih, SM [1 ]
Barary, MH [1 ]
ElSayed, MA [1 ]
Abdine, HH [1 ]
ElKersh, AM [1 ]
机构
[1] PHARCO PHARMACEUT CO,ALEXANDRIA,EGYPT
关键词
2-aminopyridine; bulk and tablets; derivative spectrophotometry; impurity in drug; high-performance liquid chromatography; tenoxicam;
D O I
10.1016/S0731-7085(96)02032-8
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Derivative spectrophotometry and high-performance liquid chromatography (HPLC) were used to determine tenoxicam and one of its decomposition products (2-aminopyridine) simultaneously and in the presence of each other. The derivative procedure was based on the linear relationship between the tenoxicam concentration and the second derivative amplitudes al 390-348 nm (peak-to-trough) measurement. The 2-aminopyridine was determined through measuring the second derivative amplitude at 241 nm (zero-crossing for tenoxicam). For the HPLC procedure. a reversed-phase Cs column with a mobile phase composed of 0.02 M sodium acetate-methanol-acetonitrile (11:8:1) with 0.005 M heptane sulfonic acid sodium salt, as an ion pair, was used to separate both compounds with 2,4-dinitrochlorobenzene, as an internal standard, in reasonable time. The flow rate was 1.5 ml min(-1) with a programmable ultraviolet (UV) detection at 300 and 375 nm. Both UV derivative spectrophotometric and HPLC approaches were followed for confirming the purity of tenoxicam in bulk and tablets dosage form. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:1923 / 1928
页数:6
相关论文
共 12 条
[1]  
Al-Obaid AM, 1993, ANAL PROFILES DRUG S, V22, P431
[2]   DETERMINATION OF 2-AMINOPYRIDINE IN PIROXICAM BY DERIVATIVE UV-SPECTROPHOTOMETRY [J].
CARLUCCI, G ;
COLANZI, A ;
MAZZEO, P ;
QUAGLIA, MG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 53 (03) :257-259
[3]   DETERMINATION OF TENOXICAM IN HUMAN PLASMA USING SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
CARLUCCI, G ;
MAZZEO, P ;
PALUMBO, G .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1992, 15 (04) :683-695
[4]   DETERMINATION OF TENOXICAM, AND THE ISOLATION, IDENTIFICATION AND DETERMINATION OF RO 17-6661, ITS MAJOR METABOLITE, IN HUMAN-URINE [J].
DELL, D ;
JOLY, R ;
MEISTER, W ;
ARNOLD, W ;
PARTOS, C ;
GULDIMANN, B .
JOURNAL OF CHROMATOGRAPHY, 1984, 317 (DEC) :483-492
[5]  
ELMAALI NA, 1989, ANAL LETT, V22, P3025
[6]   SQUARE-WAVE AND SQUARE-WAVE ADSORPTIVE STRIPPING VOLTAMMETRIC COMPARISON OF THE ANTIINFLAMMATORY DRUGS PIROXICAM AND TENOXICAM [J].
ELMAALI, NA ;
VIRE, JC ;
PATRIARCHE, GJ ;
GHANDOUR, MA ;
CHRISTIAN, GD .
ANALYTICAL SCIENCES, 1990, 6 (02) :245-250
[7]  
HEIZMANN P, 1986, J CHROMATOGRAPHY, V374
[8]  
HEIZMANN P, 1986, BIOMEDICAL APPL, V47, P95
[9]   PIROXICAM PHARMACOKINETICS IN MAN - ASPIRIN AND ANTACID INTERACTION STUDIES [J].
HOBBS, DC ;
TWOMEY, TM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (5-6) :270-281
[10]  
MUNERAJARANILLO MI, 1993, J CHROMATOGRAPHY, V616